Sign up for free insights newsletter
68

Shenzhen YHLO Biotech Co. Ltd. A

688575SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥14.24
-1.18%
End of day
Market Cap

$8.27B

P/E Ratio

55.65

Employees

1,678

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-3.30-2.50-0.25-0.18-0.85
Calmar-18.43-9.02-0.24-0.15-3.18
Sharpe-10.13-1.89-0.16-0.12-1.26
Omega0.000.660.991.000.86
Martin-27.36-19.13-0.39-0.31-5.73
Ulcer3.412.6310.408.487.72

Shenzhen YHLO Biotech Co. Ltd. A (688575) Price Performance

Shenzhen YHLO Biotech Co. Ltd. A (688575) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY14.24, down 1.18% from the previous close.

Over the past year, 688575 has traded between a low of CNY13.54 and a high of CNY16.38. The stock has lost 3.1% over this period. It is currently 13.1% below its 52-week high.

Shenzhen YHLO Biotech Co. Ltd. A has a market capitalization of $8.27B, with a price-to-earnings ratio of 55.65.

About Shenzhen YHLO Biotech Co. Ltd. A

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.

Compare Shenzhen YHLO Biotech Co. Ltd. A

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$1.81B
EBITDA
$349.89M
Profit Margin
1.33%
EPS (TTM)
0.26
Book Value
4.74

Technical Indicators

52 Week High
CN¥17.00
52 Week Low
CN¥13.51
50 Day MA
CN¥14.34
200 Day MA
CN¥14.81
Beta
0.40

Valuation

Trailing P/E
55.65
Forward P/E
N/A
Price/Sales
4.57
Price/Book
3.10
Enterprise Value
$8.84B